Literature DB >> 7430245

Microstages in malignant melanoma--the basis for an elective lymph node dissection.

J Tonak, F Weidner.   

Abstract

Our experience has shown that an increasing depth of invasion of the primary tumor is connected with a higher incidence of regional lymph node metastases. The incidence of subsequent metastases or recurrences is compared retrospectively for two groups: (1) 175 patients with elective dissection and (2) 33 patients with excision only. All patients suffered from high-risk melanomas of clinical stage I. The frequency of subsequent metastases was 21% (N = 36) for the first group and 46% (N = 15) for the second group (p less than or equal to 0.01). The 5-year survival rate (Berkson-Gage) of patients with high-risk melanomas and secondaries is 41% for the patient group (N = 27) in which elective dissection was performed and 21% for patients with therapeutic dissection (N = 52). The results speak for the elective dissection in cases of high-risk melanomas.

Entities:  

Mesh:

Year:  1980        PMID: 7430245     DOI: 10.1007/bf00408103

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Prophylactic node dissection for malignant melanoma.

Authors:  S T Norvell; J J McCleave; A J Bodurtha; A C Irwin
Journal:  Can J Surg       Date:  1977-09       Impact factor: 2.089

2.  Biostatistical basis of elective node dissection for malignant melanoma.

Authors:  J G Fortner; J Woodruff; D Schottenfeld; B Maclean
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

3.  Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.

Authors:  T K Gupta
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

4.  Malignant melanoma: the problem of lymph-node metastases.

Authors:  D C Bodenham
Journal:  Proc R Soc Med       Date:  1969-11

5.  Incontinuity versus discontinuous lymph node dissection for malignant melanoma.

Authors:  J P Shah; H S Goldsmith
Journal:  Cancer       Date:  1970-09       Impact factor: 6.860

6.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

7.  Malignant melanoma: microstages and individualized therapy.

Authors:  J Tonak; P Hermanek; H Groitl
Journal:  Aust N Z J Surg       Date:  1978-06

8.  Early metastases in regional lymph nodes and prognosis of malignant melanoma. Histological and clinical examinations in 104 lymphadenectomized patients.

Authors:  F Weidner; O P Hornstein; P Hermanek; G Wutz
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

9.  Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis.

Authors:  E V Sugarbaker; C M McBride
Journal:  Surgery       Date:  1976-07       Impact factor: 3.982

10.  A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results.

Authors:  F H Sim; W F Taylor; J C Ivins; D J Pritchard; E H Soule
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

View more
  1 in total

1.  [Surgical treatment of malignant melanomas of the skin].

Authors:  L Lukács; S Péter
Journal:  Langenbecks Arch Chir       Date:  1984
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.